Adagene
ID: 6349600Adagene is a biotechnology company using computational biology and artificial intelligence for the development of novel antibody-based cancer immunotherapies.
3
Funding Rounds
$144.0m
Money raised
Recent Funding Rounds
Overview
Adagene is a biotechnology company using computational biology and artificial intelligence for the development of novel antibody-based cancer immunotherapies.
- Website:
- Headquarters: Suzhou
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Adagene has raised a total of $75m in funding over 3 rounds.
Key Insights:
- Adagene July 2025 Venture Funding Round: $25m
- Adagene Series C round, March 2018: $50m
- Adagene Series D round January 2020: $69m
Industries
Adagene is active in the following industries: